SOLICITATION NOTICE
65 -- Peripherally_Inserted_Central_Catheters - QSL FBO Package Worksheet
- Notice Date
- 1/9/2014
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 339113
— Surgical Appliance and Supplies Manufacturing
- Contracting Office
- Defense Logistics Agency, DLA Acquisition Locations, DLA Troop Support - Medical, 700 Robbins Avenue, Philadelphia, Pennsylvania, 19111-5096, United States
- ZIP Code
- 19111-5096
- Solicitation Number
- ME-1207-45
- Point of Contact
- Mr. Tom Winkel, Phone: 011-49-6371-9464-4089, Mr. Rob Halliday, Phone: 011-49-6371-9464-4090
- E-Mail Address
-
thomas.p.winkel.ctr@mail.mil, robert.b.halliday2.ctr@mail.mil
(thomas.p.winkel.ctr@mail.mil, robert.b.halliday2.ctr@mail.mil)
- Small Business Set-Aside
- N/A
- Description
- Complete answers and all supporting documentation must be provided with the vendor’s submittal by the response date stated in the QSL FBO Sources Sought notification. A vendor who does not meet all of these requirements or who does not submit documentation to support these requirements as requested will not be qualified for the QSL. Vendor must provide responses to the Sources Sought notification via the QSL FBO Package Worksheet. The Defense Health Agency (DHA) Medical Logistics (MedLog) Division Medical Materiel Enterprise Standardization Office (MMESO) and the Defense Logistic Agency (DLA) Troop Support Medical Prime Vendor (PV) Program announce a Sources Sought Notification for the creation of a Qualified Suppliers Listing (QSL) for Peripherally Inserted Central Catheters. This is not a request for quote or proposal. The MMESO Europe is the lead MMESO for this project. These Peripherally Inserted Central Catheters products are for purchase by the Military Treatment Facilities (MTFs) of the Military Health System (MHS) and for the operational assemblages of the Army, Navy, Air Force, Marine Corps, and Naval Expeditionary Medical Support Command (NEMSCOM) and managed regionally by MMESOs North, South, Europe, Pacific and Europe, hereafter referred to as MMESOs. For information regarding DLA Troop Support Medical's PV program please access its web site at https://www.medical.dla.mil. This Sources Sought notification is intended to solicit information and products for evaluation in order to create a QSL in accordance with (IAW) FAR 9.2 for Peripherally Inserted Central Catheters. All items proposed to be included in this QSL must be on Distribution and Pricing Agreement (DAPA) for the DLA Troop Support Medical/Surgical Prime Vendor (MSPV) Program. All participating vendors must complete the certification in the DAPA Management System (DMS).The MSPV Program requires that all items be manufactured in a Trade Agreements Act (TAA) Compliant Country (as defined by FAR 52.225-5), unless it is determined that no functionally equivalent item is available from a compliant source. To be eligible for inclusion in the proposed QSL, all vendors are required to complete the DAPA TAA Certification. Any questions concerning TAA may be directed to Bill Woltjen at DLA Troop Support, William.woltjen@dla.mil, at 215-737-7124. The QSL for Peripherally Inserted Central Catheters will be established approximately June 2014 and is anticipated to be the basis of a Standardization Action. Qualified vendors will be invited approximately July 2014 to submit pricing proposals to enter into an Incentive Agreement for Peripherally Inserted Central Catheters. The government reserves the right to standardize or not standardize on Peripherally Inserted Central Catheters. A. Products & Performance Required. The MMESOs are seeking product line items in the category of Peripherally Inserted Central Catheters. Within the MHS MTFs and operational procurement this product line has an estimated annual dollar requirement of $821,405.53. This forecast is based on historical usage data during a recent 12-month period. Estimated annual demand per AOR is approximately MMESO North $109,337.34, MMESO South $92,473.19, MMESO West $446,017.54, MMESO Europe $7,517.41, and MMESO Pacific $166,060.05. Seven product groupings were found to be relevant to the scope of this standardization action and represent the clinically significant product groups for the QSL. Those seven items are considered the minimum requirement for Standardization and accounts for 66.72% ($548,113.63) of the total volume in sales, $821,405.53. The specifications for this project are shown in "Requirements to Qualify for QSL" section below. B. Instructions to Vendors Vendors interested in qualifying for inclusion in the QSL must provide an e-mail response to this QSL FBO Sources Sought notification to the lead MMESO POCs below. The vendor's responses must include all detailed information requested in the "Requirements to Qualify for QSL" section below and must also include: (1) Company name and address; (2) Company POC (Name and Phone Number, Fax Number, and E-mail address); (3) Commercial and Government Entity (CAGE) Code; and (4) Identification of the Sources Sought notification to which the vendor is responding. Due to the potential for e-mail to be lost in transmission, from network security, etc., vendors are strongly encouraged to confirm with the lead MMESO that their e-mail submission has arrived. Each submitting vendor is advised to confirm receipt; allowing adequate time for resubmission before the due date and time should a problem occur with the first submission. As part of the "Requirements to Qualify for QSL", vendors must complete and submit the QSL FBO Package Worksheet. Any vendor experiencing difficulty opening the Worksheet may contact the MMESO POCs. The MMESO POC will provide a Worksheet copy via an alternate method (fax, email or hard copy). Vendors that do not meet the deadline of COB 5:00 PM Eastern Standard Time (EST) on the date listed for closing in this QSL FBO Sources Sought notification will not be included in the lead MMESO's review to establish the instant QSL and thus will not be able to participate in the subsequent Standardization Action. C. Source Selection Procedures The MMESO Joint Product Review Board (JPRB) will serve as the forum for clinical recommendations for product selection and coordinate logistics efforts in support of DoD Components. The board is chaired by Designated Senior Logisticians (DSLs) and co-chaired by Designated Senior Clinicians (DSCs) in the MMESO Areas of Responsibility (AORs) and includes clinicians and logisticians for MTFs within each MMESO. The Clinical Advisory Committee (CAC) members are the deciding officials for this initiative. The MMESO DSLs and DSCs intend to review responses and evaluate products for selection to the QSL IAW FAR 9.2. Requirements to Qualify for QSL Based on the standards identified above, the product specific and clinical requirements will be rated as "Meets requirement" or "Does not meet requirement". The clinical evaluation will be conducted in a non-patient treatment setting. The Enterprise SMEs identified the following requirements for this product line. Vendor must meet all requirements to be placed on the QSL. A vendor who does not meet all of these requirements or who does not submit documentation to support these requirements as requested will not be qualified for the QSL. Vendor must provide responses to the Sources Sought notification via the QSL FBO Package Worksheet. 1. Vendor must have a DAPA or be in the process of applying for a DAPA number for the product line listed. Vendor must provide their DAPA number or provide documentation and date the DAPA number was applied for. Vendors who do not continue to process their application for a DAPA number will not be considered for continued participation. 2. Vendor must have an agreement with the current DoD Medical/Surgical Prime Vendor CARDINAL HEALTH, or must work with CARDINAL HEALTH to initiate an agreement. 3. Vendor must have an agreement with the current DoD Medical/Surgical Prime Vendor OWENS & MINOR, or must work with OWENS & MINOR to initiate an agreement. 4. Vendor must have a government issued Commercial and Government Entity (CAGE) code assigned for products contained within the specific product group or be in the process of obtaining one. Vendor's who previously had an active record in Central Contractor Registration (CCR) must validate that their account is Active in the System for Award Management (SAMs) and provide Cage Code. Vendors in the process of obtaining a Cage Code must provide documentation to support that they have registered in SAMs. Vendor's who do not continue to process application for a CAGE Code and/or a SAMs account, will not be considered for continued participation. See https://www.sam.gov/portal/public/SAM/. 5. Vendor must provide the following items listed. Vendor must provide product catalog, literature, and instructions for use (IFU) for any items offered in response to this Sources Sought Notification. Vendor must submit the following information via QSL FBO Package Worksheet for each offered product: Full item description, Distributor Part Number, Manufacturer Part Number, Manufacturer Name, and Number of eaches in Unit of Sale. Only ONE Vendor Part Number (PN) should be provided for each item/sample. Required Products / Units (total eaches) PICC 5 to 5.5 FR 55 to 65 centimeters long (CML) Dual Lumen Maximum Barrier Tray / 836 PICC 5 to 5.5 FR 55 to 65 CML Dual Lumen Basic Tray / 803 PICC 5 to 5.5 FR 55 to 65 CML Dual Lumen Full Procedure Tray / 325 PICC 4 FR 55 to 65 CML Single Lumen Maximum Barrier Tray / 189 PICC 6 FR 55 to 65 CML Triple Lumen Full Procedure Tray / 155 PICC 6 FR 55 to 65 CML Triple Lumen Maximum Barrier Tray / 96 PICC 4 to 4.5 FR 55 to 65 CML Single Lumen Full Procedure Tray / 55 6. Vendor must provide latex free or latex safe Peripherally Inserted Central Catheter tray items, and provide documentation to support this with initial submittal. 7. Vendor must provide sterile Peripherally Inserted Central Catheter tray items, and provide documentation to support this with initial submittal. 8. Vendor must provide single use Peripherally Inserted Central Catheter tray items, and provide documentation to support this with initial submittal. 9. Vendor must provide Peripherally Inserted Central Catheter Basic Trays which include the following minimum items and documentation to support this with initial submittal: one-PICC (power injectable, if multi-lumen, at least one lumen is designated pressure injectable), one-introducer needle, one-guidewire, one-dilator (catheter specific), one- 5-12 ml Luer-Lock syringe, and one-dead end cap per lumen. 10. Vendor must provide Peripherally Inserted Central Catheter Full Procedure Trays which include the following minimum items and documentation to support this with initial submittal: one-PICC (power injectable, if multi-lumen, at least one lumen is designated pressure injectable), one-introducer needle, one-guidewire, one-dilator (catheter specific), one-catheter catheter 18 2.5 inches over 20 GA needle or one-20g 1.75 inches over 22GA needle, one-prefilled 10 ml.9% normal saline luer-lock syringe/per lumen, one-dead cap per lumen, one-21g or 22g safety needle, one-25g safety needle, one-5ml ampule 1% Lidocaine, one-small Sharps/needle holder device, one-orange tint 2% chlorhexidine gluconate (CHG) with 70% isopropyl alcohol (IPA) 3.0 ml applicator, one-colorless tint 2%CHG with 70%IPA 3.0 ml applicator, One-24-23" x 36-41" fenestrated drape with 4" fenestration, two-2"x2" gauze sponges, five-4"x4" gauze sponges, one-5-12 ml luer lock syringe, one-disposable #11 safety scalpel, one-tape measure, one-CSR wrap, and one-disposable towel (absorbent). 11. Vendor must provide Peripherally Inserted Central Catheter Maximum Barrier Trays which include the following minimum items and documentation to support this with initial submittal: one-PICC (power injectable, if multi-lumen, at least one lumen is designated pressure injectable), one-introducer needle, one-guidewire, one-dilator (catheter specific), one-catheter catheter 18 2.5 inches over 20 GA needle or one-20g 1.75 inches over 22GA needle, one-prefilled 10 ml.9% normal saline luer-lock syringe/per lumen, one-dead end cap per lumen, one-21 or 22g safety needle, one-25g safety needle, one-5ml ampule 1% Lidocaine, one-small Sharps/needle holder device, one-orange tint 2% chlorhexidine gluconate (CHG) with 70% isopropyl alcohol (IPA) 3.0 ml applicator, one-colorless tint 2%CHG with 70%IPA 3.0 ml applicator, One-24-23" x 36-41" fenestrated drape with 4" fenestration, two-2"x2" gauze sponges, five-4"x4" gauze sponges, one-5-12 ml luer lock syringe, one-disposable #11 safety scalpel, one-tape measure, one-CSR wrap, one-disposable towel (absorbent), one-sterile scissors, one-full length body drape (maximum barrier) with or without 4" fenestration, one-bouffant cap, one-impervious gown (size large), and one-mask with eye shield. 12. Vendor must provide safety hypodermic needles as part of the Peripherally Inserted Central Catheter tray and documentation to support this with initial submittal. 13. Vendor must provide safety scalpels as part of the Peripherally Inserted Central Catheter tray and documentation to support this with initial submittal. 14. Vendor must provide a safe storage area or device in the Peripherally Inserted Central Catheter tray that secures the introducer needle and documentation to support this with initial submittal. 15. Vendor must provide Peripherally Inserted Central Catheters that have centimeter spacing markers from the distal tip to the proximal hub and documentation to support this with initial submittal. 16. Vendor must provide Peripherally Inserted Central Catheters which are radiopaque and documentation to support this with initial submittal. 17. Vendor must provide Peripherally Inserted Central Catheter trays that open without contaminating the sterile contents within the tray. 18. Vendor must provide Peripherally Inserted Central Catheters which connect securely to the catheter port and do not leak. 19. Vendor must provide Peripherally Inserted Central Catheters with a tip which remains free from fraying or loose catheter material when the catheter is trimmed. 20. Vendor MAY provide any or all of the additional items listed below, following the same format as for requirement number 5. Additional Products PICC 5FR 55CML Triple Lumen Full Procedure Tray PICC 4FR 55 CML Dual Lumen Full Procedure Tray PICC 5FR 55 CML Single Lumen Basic Tray PICC 5FR 55 CML Triple Lumen Maximum Barrier Tray PICC 5FR 50 CML Double Lumen Maximum Barrier Tray PICC 5FR 45 CML Dual Lumen Full Procedure Tray PICC 4FR 50 to 55 CML Single Lumen Basic Tray PICC 3FR 45 CML Single Lumen Maximum Barrier Tray Antimicrobial PICC 5FR 50 CML Dual Lumen Basic Tray Antimicrobial PICC 5FR 50 CML Dual Lumen Basic Tray Pediatric 1.9FR 50 CML Single Lumen Catheter Only Pediatric PICC 2.0FR 30 CML Single Lumen Full Procedure Tray PICC 3FR 45 CML Single Lumen Full Procedure Tray Neonate/Pediatric PICC 1.9 to 2.0FR 30 CML Single Lumen Basic Tray PICC 6FR 55 CML Triple Lumen Basic Tray PICC 5FR 50 CML Dual Lumen Basic Tray Antimicrobial PICC 6FR 58 CML Dual Lumen Basic Tray PICC 6FR 55 CML Dual Lumen Basic Tray Antimicrobial 6FR 60CML Triple Lumen Basic Tray Pediatric PICC 1.9FR 30CML Dual Lumen Basic Tray Antimicrobial 4FR 60 CML Single Lumen Basic Tray Pediatric PICC 2FR 30 CML Single Lumen Catheter Only PICC 4FR 76 CML Dual Lumen Basic Tray Antimicrobial PICC 5.5FR 55 CML Dual Lumen Maximum Barrier Tray Neonate/Pediatric PICC 1.9FR 35 CML Single Lumen Full Procedure Tray PICC 5FR 55 CML Single Lumen Full Procedure Tray PICC 4FR 45 CML Single Lumen Full Procedure Tray Antimicrobial PICC 5FR 50 CML Dual Lumen Catheter Only PICC 3FR 76 CML Single Lumen Basic Tray PICC 5FR 55CML Single Lumen Basic Tray PICC 1FR 20 CML Single Lumen Basic Tray (minus) PICC 4FR 40 CML Single Lumen Maximum Barrier Tray Neonate/Pediatric PICC 1.9FR 50 CML Single Lumen Maximum Barrier Tray PICC 3FR 45 CML Single Lumen Basic Tray PICC 4FR 55 CML Dual Lumen Maximum Barrier Tray PICC 7FR 60 CML Dual Lumen Full Procedure Tray PICC 3FR 55 CML Single Lumen Basic Tray PICC 4FR 60 CML Dual Lumen Basic Tray PICC 4FR 50 CML Dual Lumen Basic Tray PICC 4FR 50 CML Single Lumen Full Procedure Tray PICC 4FR 40 CML Single Lumen Basic Tray Evaluation After the lead MMESO receives all information required above, they will send each vendor making a complete and approved submission a written request to provide product samples to Clinical Product Team (CPT) members at the participating MTFs. MTF "Ship to" Addresses will be provided as part of the request. To ensure your eligibility to participate, all products required for evaluation must be shipped no later than 14 calendar days from issuance of the MMESO's request and must arrive at all designated MTFs no later than 5:00 PM local time at delivery location, 30 calendar days from issuance of the MMESO's request. Any products received beyond the stated date and time will not be included in the Clinical Process Teams' (CPT) reviews to establish the instant QSL and to participate in the subsequent Standardization Action, but will be destroyed upon receipt. Vendor will provide only the following products for evaluation. The products will be provided at no cost to the government for products or delivery, and unused products will not be returned. Three each (not three cases) of the item listed is to be provided as product samples to each of the evaluation sites as requested by the Lead MMESO. Vendor will be required to send same part number(s) as provided in the QSL FBO Package Worksheet. Item to Send Peripherally Inserted Central Catheter 5 to 5.5Fr 55 to 65 CML Dual Lumen, Maximum Barrier Tray There will be approximately 14 MTFs enterprise wide that will be evaluating products. Each evaluator will evaluate the vendor submissions in the Peripherally Inserted Central Catheter Tray product line. The MMESO CPT will review the responses from the vendors and the results from the product evaluations and determine which vendors meet the requirements. A vendor who provides all requested information and meets the requirements will be selected for inclusion in the QSL. Vendors will be notified of whether they met or did not meet the QSL requirements by approximately June 2014. Points of Contact (POCs): Mr. Thomas Winkel, MMESO Europe Team Leader, thomas.p.winkel.ctr@mail.mil, (49) 6371-9464-4089; and Mr. Robert Halliday, MMESO Europe Clinical Analyst, robert.b.halliday2.ctr@mail.mil, (49) 6371-9464-4090. DLA Troop Support Medical Contracting Officer: Tara J. Perrien, tara.j.perrien@dla.mil (215) 737-8307.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DLA/J3/DSCP-M/ME-1207-45/listing.html)
- Place of Performance
- Address: ERMC HQ, CMR 402 box 219, Dept G4, Bldg 3739, Rm 222, Landstuhl, Rhineland-Palatinate, Non-U.S., APO 09180-, United States
- Record
- SN03264453-W 20140111/140109234839-fe6760c9e89bd208e80330cefc179364 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |